Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Urinary Bladder Neoplasms 8Glioblastoma 3Squamous Cell Carcinoma of Head and Neck 2Melanoma 2Brain Neoplasms 2Urothelial Carcinoma of the Bladder 1Sarcoma 1Oligodendroglioma 1Non-Muscle Invasive Bladder Urothelial Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Muscle-invasive Urothelial Cancer of the Bladder 1Mouth Neoplasms 1Lymphoma, Follicular 1Laryngeal Neoplasms 1Glioma 1Giant Cell Tumor of Bone 1Ganglioneuroblastoma 1Estrogen Receptor Positive Breast Cancer 1Craniopharyngioma 1Carcinoma 1Astrocytoma 1Alzheimer Disease 1

Interventions

Methods 2pomalidomide 1fasudil 1XENP 1595 1UE2343 1Transurethral Resection of Bladder 1Telemedicine 1Surgical Procedures, Operative 1Standard of Care 1Hormones 1Exercise 1Ethanol 1Electroencephalography 1Drug Delivery Systems 1Dexamethasone 1Control Groups 1Amputation, Surgical 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alzheimer Disease × Transurethral Resection of Bladder × 1 year × Clear all
NCT07227961 2025-11-13

PROMIS and Mobility Evaluation in Sarcoma Patients

University of Calgary

Recruiting
800 enrolled
Sarcoma

Alzheimer Disease, Sarcoma, Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡